These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Interleukin-2 suppression in cats naturally infected with feline leukemia virus. Author: Tompkins MB, Ogilvie GK, Gast AM, Franklin R, Weigel R, Tompkins WA. Journal: J Biol Response Mod; 1989 Feb; 8(1):86-96. PubMed ID: 2537886. Abstract: Feline peripheral blood lymphocytes (PBLs) produce interleukin-2 (IL-2) when stimulated with concanavalin A (Con A) or the combination of the Ca2+ ionophore A23187 (A2) plus the phorbol ester phorbol-12-myristate-13-acetate (PMA). To determine the status of T helper cell function in cats naturally infected with feline leukemia virus (FeLV), PBLs from 19 normal cats and 49 FeLV-infected (34 asymptomatic and 15 symptomatic) cats were tested for their ability to produce IL-2 in response to Con A or A2/PMA stimulation. In the case of Con A stimulation, 21, 41, and 67% of normal, FeLV-infected asymptomatic, and FeLV-infected symptomatic cats, respectively, failed to produce detectable levels of IL-2. In contrast, A2/PMA stimulation yielded high titers of IL-2 in 100% of the normal cats, 92% of asymptomatic cats, but only 44% of clinically ill cats. All of the A2/PMA nonresponders in the FeLV-infected symptomatic population were also unresponsive to Con A. T Helper immunosuppression was observed in cats with FeLV-induced lymphoproliferative diseases as well as cats with FeLV-associated acquired immune deficiency syndrome-like diseases. These data suggest that TH immunosuppression in naturally infected viremic cats may precede development of clinical disease. Moreover, the ability to restore TH function with A2/PMA is diminished with development of clinical disease.[Abstract] [Full Text] [Related] [New Search]